Inflammatory status in older women with and without metabolic syndrome: Is there a correlation with risk factors?

Clinical Interventions in Aging

Volumn 8, Issue , 2013, Pages 361-367

  Silva, Alessandro de Oliveira ^a,b   Tibana, Ramires Alsamir ^a   Karnikowski, Margo Gomes Oliveira ^c   Funghetto, Silvana Schwerz ^c   Prestes, Jonato ^a  

^a UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^b Undergraduates of Medicine in the University Center of Brasilia   (Brazil)

^c UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Aging; Cytokines; Metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INFLAMMATORY STATUS; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MEDICAL PARAMETERS; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PATIENT ASSESSMENT; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO;

AGING; CYTOKINES; METABOLIC SYNDROME;

ABSORPTIOMETRY, PHOTON; AGED; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERFERON-GAMMA; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE;

EID: 84875641545     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S39899     Document Type: Article

References (22)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-1428.
2. Cornier MA, Dabelea D, Hernandez TL, etal. The metabolic syndrome. Endocr Rev. 2008;29(7):777-822.
3. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26(3): 575-581.
4. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163(4):427-436.
5. Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP. The prevalence of metabolic syndrome in various populations. Am J Med Sci. 2007;333(6):362-371.
6. Dutra ES, de Carvalho KM, Miyazaki E, Hamann EM, Ito MK. Metabolic syndrome in central Brazil: prevalence and correlates in the adult population. Diabetol Metab Syndr. 2012;4(1):20.
7. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-867.
8. Pischon T, Hu FB, Rexrode KM, Girman CJ, Manson JE, Rimm EB. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis. 2008;197(1):392-399.
9. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97(2A):3A-11A.
10. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121(6):2111-2117.
11. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care. 2002;25(11):2016-2021.
12. Prestes J, Shiguemoto G, Botero JP, etal. Effects of resistance training on resistin, leptin, cytokines, and muscle force in elderly post-menopausal women. J Sports Sci. 2009;27(14):1607-1615.
13. Katsuki A, Sumida Y, Gabazza EC, etal. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. DiabetesCare. 2001;24(2):362-365.
14. Sociedade Brasileira de Cardiologia. VI diretriz Brasileira de hipertensao [VI Brazilian guidelines on hypertension]. Arq Bras Cardiol. 2010;95(Suppl 1):1-51. Portuguese.
15. Johnson JL, Slentz CA, Houmard JA, etal. Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention Through Defined Exercise). Am J Cardiol. 2007;100(12):1759-1766.
16. Banks WA, Willoughby LM, Thomas DR, Morley JE. Insulin resistance syndrome in the elderly: assessment of functional, biochemical, metabolic, and inflammatory status. Diabetes Care. 2007;30(9):2369-2373.
17. Yang WS, Yang YC, Chen CL, etal. Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr. 2007;86(2):509-513.
18. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159(10):1104-1109.
19. Cabrera MA, de Andrade SM, Mesas AE. A prospective study of risk factors for cardiovascular events among the elderly. Clin Interv Aging. 2012;7:463-468.
20. Lewis SJ, Rodbard HW, Fox KM, Grandy S. Self-reported prevalence and awareness of metabolic syndrome: findings from SHIELD. Int J Clin Pract. 2008;62(8):1168-1176.
21. Chen SJ, Yen CH, Huang YC, Lee BJ, Hsia S, Lin PT. Relationships between inflammation, adiponectin, and oxidative stress in metabolic syndrome. PLoS One. 2012;7(9):e45693.
22. Ingelsson E, Hulthe J, Lind L. Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest. 2008;38(7):502-509.